理解急性呼吸窘迫综合征患者的死亡原因:一项叙述性综述
该叙述性综述检索PubMed(2015年1月至2024年4月)等来源,纳入报告≥30例ARDS患者死亡原因的观察性研究和临床试验,排除动物研究、病例报告、综述、研究方案和儿科研究。共纳入15项观察性研究(9项非COVID ARDS,5项COVID相关ARDS,1项两者兼有)和5项临床试验(均为非COVID ARDS)。仅8项研究使用互斥的预设分类记录死亡原因,且分类和定义各异。当多器官衰竭为预设分类时,它是最常见死因(约50%死亡),其次为呼吸原因(比例16%–42%不等);但非COVID ARDS最大观察性研究(964例死亡)未将多器官衰竭设为预设分类,发现肺衰竭(42%)和心脏衰竭(37%)最常见;COVID相关ARDS观察性研究中呼吸原因报告最多(高达88%)。结论指出报告ARDS死因的研究少、分类定义异质,需进一步研究更严谨统一的死因判定和报告方法。
要点
- 多器官衰竭作为预设分类时是最常见死因,约占ARDS死亡的50%,其次为呼吸原因(16%–42%不等)。
- 非COVID ARDS最大观察性研究(964例死亡)未预设多器官衰竭分类,报告肺衰竭(42%)和心脏衰竭(37%)为最常见死因。
- COVID相关ARDS观察性研究中,呼吸原因是最常报告的死因,高达88%。
- 仅8项研究使用互斥的预设分类记录死因,且各研究分类和定义不同,死因归类异质。
- 共纳入15项观察性研究(9项非COVID、5项COVID相关、1项两者兼有)和5项临床试验(均为非COVID ARDS),报告ARDS死因的研究数量少。
适用人群与场景
- 报告死亡原因的ARDS患者,研究纳入标准为报告≥30例ARDS患者死亡原因的观察性研究和临床试验;排除动物研究、病例报告、综述、研究方案和儿科研究。
诊断标准与关键阈值
- 研究纳入标准:报告≥30例ARDS患者死亡原因的观察性研究或临床试验,且死因非来自死亡证明。
- 仅8项研究使用互斥的预设分类记录死亡原因,但各研究分类和定义不同。
研究设计与关键结果
- 共纳入15项观察性研究(9项非COVID ARDS,5项COVID相关ARDS,1项两者兼有)和5项临床试验(均为非COVID ARDS)。
- 仅8项研究使用互斥的预设分类记录死亡原因,研究间分类和定义存在差异。
- 当多器官衰竭为预设分类时,它是最常见死因(约占50%的死亡),其次为呼吸原因,比例因命名(如难治性低氧血症、肺部原因)和定义不同而介于16%至42%。
- 非COVID ARDS最大观察性研究(964例死亡)未将多器官衰竭设为预设分类,发现肺衰竭(42%)和心脏衰竭(37%)为最常见死因。
- COVID相关ARDS观察性研究中,呼吸原因是最常报告的死因(高达88%)。
证据类型、等级与局限
- 证据类型:叙述性综述,汇总15项观察性研究和5项临床试验。
- 局限:原文未报告局限性;结论指出报告ARDS死因的研究少、分类和定义异质,需进一步研究更严谨统一的死因判定和报告方法。
对床旁实践的改变
- 作者认为需要进一步研究更严谨统一的ARDS死因判定和报告方法,以帮助确定临床试验中评估靶向治疗更相关的终点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To provide a comprehensive summary of the published data on cause of death in patients with acute respiratory distress syndrome (ARDS).
DATA SOURCES: PubMed (January 2015 to April 2024), bibliographies of relevant articles, and ARDS Network and Prevention & Early Treatment of Acute Lung Injury (PETAL) network websites.
STUDY SELECTION: Observational studies and clinical trials that reported on cause of death in greater than or equal to 30 patients with ARDS, not obtained from death certificates. Animal studies, case reports, review articles, study protocols, and studies in pediatrics were excluded.
DATA EXTRACTION: Causes of death among ARDS patients who died were extracted and tabulated along with other pertinent study characteristics.
DATA SYNTHESIS: We identified 15 observational studies (nine non-COVID ARDS, five COVID-related ARDS; one both) and five clinical trials (all non-COVID ARDS). Mutually exclusive prespecified categories were used for recording the cause of death in only eight studies although studies differed in the categories included and their definitions. When multiple organ failure was a predetermined category, it was the most common cause of death recorded (~50% of deaths), followed by respiratory causes with proportions varying from 16% to 42% depending on nomenclature (e.g., refractory hypoxemia, pulmonary causes) and definitions. However, the largest observational study in non-COVID ARDS (964 deaths), did not include multiple organ failure as a predetermined category, and found that pulmonary failure (42%) and cardiac failure (37%) were the most common causes of death. In COVID-related ARDS observational studies, pulmonary reasons were the most reported cause of death (up to 88%).
CONCLUSIONS: Few studies have reported cause of death in patients with ARDS. In those that do, cause of death categories and definitions used are heterogeneous. Further research is needed to see whether a more rigorous and unified approach to assigning and reporting cause of death in ARDS would help identify more relevant endpoints for the assessment of targeted treatments in clinical trials.
参考来源
- Bromley SE, Shakery K, Vora P, et al. Understanding Causes of Death in Patients With Acute Respiratory Distress Syndrome: A Narrative Review. Crit Care Explor. 2024. PMID: 39172623. doi:10.1097/CCE.0000000000001147
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。